Clinical significance of revised microscopic positive resection margin status in ductal adenocarcinoma of pancreatic head

被引:9
作者
You, Yunghun [1 ]
Choi, Dong Wook [2 ]
Heo, Jin Seok [2 ]
Han, In Woong [2 ]
Choi, Seong Ho [3 ]
Jang, Kee-Taek [4 ]
Han, Sunjong [5 ]
Han, Sang Hyup [6 ]
机构
[1] Konkuk Univ, Sch Med, Konkuk Univ Choongju Hosp, Dept Surg, Chungju, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, 81 Irwon Ro, Seoul 06351, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Surg, Chang Won, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Surg, Seongnam, South Korea
[6] Yonsei Univ, Coll Med, Dept Hepatobiliary & Pancreat Surg, Seoul, South Korea
关键词
Pancreatic ductal carcinoma; Margins of excision; Pancreaticoduodenectomy; Survival; Recurrence; CANCER SURGERY; SURVIVAL; PANCREATICODUODENECTOMY; CLEARANCE; METAANALYSIS; RECURRENCE;
D O I
10.4174/astr.2019.96.1.19
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Recent studies have suggested microscopic positive resection margin should be revised according to the presence of tumor cells within 1mm of the margin surface in resected specimens of pancreatic cancer. However, the clinical meaning of this revised margin status for R1 resection margin was not fully clarified. Methods: From July 2012 to December 2014, the medical records of 194 consecutive patients who underwent pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head were analyzed retrospectively. They were divided into 3 groups on margin status; revised microscopic negative margin (rRO) - tumor exists more than 1 mm from surgical margin, revised microscopic positive margin (rR1) - tumor present within less than 1 mm from surgical margin, classic microscopic positive margin (cR1) - tumor is exposed to surgical margin. Results: There were 76 rR0 (39,2%), 100 rR1 (51.5%), and 18 cR1 (9.3%), There was significant difference in disease-free survival rates between cR1 vs. rR1 (8.4 months vs. 24.0 months, P = 0.013). Margin status correlated with local recurrence rate (17.1% in rR0, 26.0% in rR1, and 44.4% in cR1, P = 0.048). There is significant difference in recurrence at tumor bed (11.8% in rR0 vs. 23.0 in rR1, P = 0.050). Of rR1, adjuvant treatment was found to be an independent risk factor for local recurrence (hazard ratio, 0.297; 95% confidence interval, 0.127-0.693, P = 0.005). Conclusion: Revised R1 resection margin (rR1) affects recurrence at the tumor bed. Adjuvant treatment significantly reduced local recurrence of rR1. Accordingly, adjuvant chemoradiation for rR1 group should be taken into account.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 50 条
  • [31] Resection Margin Status and Long-Term Outcomes after Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Tertiary Referral Center Analysis
    Quero, Giuseppe
    De Sio, Davide
    Fiorillo, Claudio
    Lucinato, Chiara
    Panza, Edoardo
    Biffoni, Beatrice
    Langellotti, Lodovica
    Laterza, Vito
    Scaglione, Giulia
    Taglioni, Flavia
    Massimiani, Giuseppe
    Menghi, Roberta
    Rosa, Fausto
    Mezza, Teresa
    Alfieri, Sergio
    Tondolo, Vincenzo
    CANCERS, 2024, 16 (13)
  • [32] Clinical Impact of Preoperative Biliary Drainage in Patients with Ductal Adenocarcinoma of the Pancreatic Head
    Amaral, Maria Joao
    Freitas, Joao
    Amaral, Mariana
    Serodio, Marco
    Oliveira, Rui Caetano
    Donato, Paulo
    Tralhao, Jose Guilherme
    DIAGNOSTICS, 2023, 13 (07)
  • [33] Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma
    Chen, Jiong
    Chen, Long-Jiang
    Yang, Ren-Bao
    Xia, Yun-Lian
    Zhou, Hang-Cheng
    Wu, Wen
    Lu, Yin
    Hu, Li-Wei
    Zhao, Yue
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [34] Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma
    Ang, Andrew
    Michaelides, Athena
    Chelala, Claude
    Ullah, Dayem
    Kocher, Hemant M.
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (02) : 248 - 261
  • [35] Clinical significance and predictors of complete or near-complete histological response to preoperative chemoradiotherapy in patients with localized pancreatic ductal adenocarcinoma
    Murata, Yasuhiro
    Mizuno, Shugo
    Kishiwada, Masashi
    Uchida, Katsunori
    Noguchi, Daisuke
    Gyoten, Kazuyuki
    Hayasaki, Aoi
    Fujii, Takehiro
    Iizawa, Yusuke
    Tanemura, Akihiro
    Kuriyama, Naohisa
    Sakurai, Hiroyuki
    Isaji, Shuji
    PANCREATOLOGY, 2021, 21 (08) : 1482 - 1490
  • [36] Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion
    Han, Sunjong
    Choi, Dong Wook
    Choi, Seong Ho
    Heo, Jin Seok
    Han, In Woong
    You, Yung Hun
    ASIAN JOURNAL OF SURGERY, 2021, 44 (01) : 313 - 320
  • [37] Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer
    Chopra, Asmita
    Zenati, Mazen
    Hogg, Melissa E.
    Zeh, Herbert J., III
    Bartlett, David L.
    Bahary, Nathan
    Zureikat, Amer H.
    Beane, Joal D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7759 - 7769
  • [38] Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma
    Epstein, Jeffrey D.
    Kozak, Geoffrey
    Fong, Zhi Ven
    He, Jin
    Javed, Ammar A.
    Joneja, Upasana
    Jiang, Wei
    Ferrone, Cristina R.
    Lillemoe, Keith D.
    Cameron, John L.
    Weiss, Matthew J.
    Lavu, Harish
    Yeo, Charles J.
    Fernandez-del Castillo, Carlos
    Wolfgang, Christopher L.
    Winter, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (06) : 658 - 664
  • [39] Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
    Sahakyan, Mushegh A.
    Verbeke, Caroline S.
    Tholfsen, Tore
    Ignjatovic, Dejan
    Kleive, Dyre
    Buanes, Trond
    Lassen, Kristoffer
    Rosok, Bard I.
    Labori, Knut Jorgen
    Edwin, Bjorn
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 366 - 375
  • [40] Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma
    Katou, Shadi
    Wenning, Anna Silvia
    Aeschbacher, Pauline
    Morgul, Haluk
    Becker, Felix
    Pascher, Andreas
    Gloor, Beat
    Struecker, Benjamin
    Andreou, Andreas
    SURGERY, 2023, 174 (01) : 91 - 99